These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 23016508

  • 1. Prevention of preterm birth: a randomized trial of vaginal compared with intramuscular progesterone.
    Maher MA, Abdelaziz A, Ellaithy M, Bazeed MF.
    Acta Obstet Gynecol Scand; 2013 Feb; 92(2):215-22. PubMed ID: 23016508
    [Abstract] [Full Text] [Related]

  • 2. A randomised trial to compare 200 mg micronised progesterone effervescent vaginal tablet daily with 250 mg intramuscular 17 alpha hydroxy progesterone caproate weekly for prevention of recurrent preterm birth.
    Shambhavi S, Bagga R, Bansal P, Kalra J, Kumar P.
    J Obstet Gynaecol; 2018 Aug; 38(6):800-806. PubMed ID: 29557230
    [Abstract] [Full Text] [Related]

  • 3. Vaginal progesterone vs intramuscular 17α-hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth in singleton gestations: systematic review and meta-analysis of randomized controlled trials.
    Saccone G, Khalifeh A, Elimian A, Bahrami E, Chaman-Ara K, Bahrami MA, Berghella V.
    Ultrasound Obstet Gynecol; 2017 Mar; 49(3):315-321. PubMed ID: 27546354
    [Abstract] [Full Text] [Related]

  • 4. A randomized controlled trial of intramuscular versus vaginal progesterone for the prevention of recurrent preterm birth.
    Elimian A, Smith K, Williams M, Knudtson E, Goodman JR, Escobedo MB.
    Int J Gynaecol Obstet; 2016 Aug; 134(2):169-72. PubMed ID: 27168167
    [Abstract] [Full Text] [Related]

  • 5. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial.
    Hassan SS, Romero R, Vidyadhari D, Fusey S, Baxter JK, Khandelwal M, Vijayaraghavan J, Trivedi Y, Soma-Pillay P, Sambarey P, Dayal A, Potapov V, O'Brien J, Astakhov V, Yuzko O, Kinzler W, Dattel B, Sehdev H, Mazheika L, Manchulenko D, Gervasi MT, Sullivan L, Conde-Agudelo A, Phillips JA, Creasy GW, PREGNANT Trial.
    Ultrasound Obstet Gynecol; 2011 Jul; 38(1):18-31. PubMed ID: 21472815
    [Abstract] [Full Text] [Related]

  • 6. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial.
    O'Brien JM, Adair CD, Lewis DF, Hall DR, Defranco EA, Fusey S, Soma-Pillay P, Porter K, How H, Schackis R, Eller D, Trivedi Y, Vanburen G, Khandelwal M, Trofatter K, Vidyadhari D, Vijayaraghavan J, Weeks J, Dattel B, Newton E, Chazotte C, Valenzuela G, Calda P, Bsharat M, Creasy GW.
    Ultrasound Obstet Gynecol; 2007 Oct; 30(5):687-96. PubMed ID: 17899572
    [Abstract] [Full Text] [Related]

  • 7. Matched sample comparison of intramuscular versus vaginal micronized progesterone for prevention of preterm birth.
    El-Gharib MN, El-Hawary TM.
    J Matern Fetal Neonatal Med; 2013 May; 26(7):716-9. PubMed ID: 23205864
    [Abstract] [Full Text] [Related]

  • 8. The association of different progesterone preparations with preterm birth prevention.
    Krispin E, Hadar E, Chen R, Wiznitzer A, Kaplan B.
    J Matern Fetal Neonatal Med; 2019 Oct; 32(20):3452-3457. PubMed ID: 29699436
    [Abstract] [Full Text] [Related]

  • 9. Vaginal progesterone combined with cervical pessary: A chance for pregnancies at risk for preterm birth?
    Stricker N, Timmesfeld N, Kyvernitakis I, Goerges J, Arabin B.
    Am J Obstet Gynecol; 2016 Jun; 214(6):739.e1-739.e10. PubMed ID: 26692180
    [Abstract] [Full Text] [Related]

  • 10. Vaginal compared with intramuscular progestogen for preventing preterm birth in high-risk pregnant women (VICTORIA study): a multicentre, open-label randomised trial and meta-analysis.
    Choi SJ, Kwak DW, Kil K, Kim SC, Kwon JY, Kim YH, Na S, Bae JG, Cha HH, Shim JY, Oh KY, Lee KA, Kim SM, Cho IA, Lee SM, Cho GJ, Jo YS, Choi GY, Choi SK, Hur SE, Hwang HS, Kim YJ, from The Preterm Birth Research Committee of the Korean Society of Maternal Fetal Medicine.
    BJOG; 2020 Dec; 127(13):1646-1654. PubMed ID: 32536019
    [Abstract] [Full Text] [Related]

  • 11. Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial.
    DeFranco EA, O'Brien JM, Adair CD, Lewis DF, Hall DR, Fusey S, Soma-Pillay P, Porter K, How H, Schakis R, Eller D, Trivedi Y, Vanburen G, Khandelwal M, Trofatter K, Vidyadhari D, Vijayaraghavan J, Weeks J, Dattel B, Newton E, Chazotte C, Valenzuela G, Calda P, Bsharat M, Creasy GW.
    Ultrasound Obstet Gynecol; 2007 Oct; 30(5):697-705. PubMed ID: 17899571
    [Abstract] [Full Text] [Related]

  • 12. [Progesterone for Prevention of Preterm Birth--Evidence-based Indications].
    Kuon RJ, Abele H, Berger R, Garnier Y, Maul H, Schleußner E, Rath W, Experts for the Prediction and Prevention of Preterm Birth (X4PB) – www.x4pb.de.
    Z Geburtshilfe Neonatol; 2015 Jun; 219(3):125-35. PubMed ID: 26114408
    [Abstract] [Full Text] [Related]

  • 13. Pessary or Progesterone to Prevent Preterm delivery in women with short cervical length: the Quadruple P randomised controlled trial.
    van Zijl MD, Koullali B, Naaktgeboren CA, Schuit E, Bekedam DJ, Moll E, Oudijk MA, van Baal WM, de Boer MA, Visser H, van Drongelen J, van de Made FW, Vollebregt KC, Muller MA, Bekker MN, Brons JTJ, Sueters M, Langenveld J, Franssen MT, Schuitemaker NW, van Beek E, Scheepers HCJ, de Boer K, Tepe EM, Huisjes AJM, Hooker AB, Verheijen ECJ, Papatsonis DN, Mol BWJ, Kazemier BM, Pajkrt E.
    BMC Pregnancy Childbirth; 2017 Sep 04; 17(1):284. PubMed ID: 28870155
    [Abstract] [Full Text] [Related]

  • 14. Pessary Compared With Vaginal Progesterone for the Prevention of Preterm Birth in Women With Twin Pregnancies and Cervical Length Less Than 38 mm: A Randomized Controlled Trial.
    Dang VQ, Nguyen LK, Pham TD, He YTN, Vu KN, Phan MTN, Le TQ, Le CH, Vuong LN, Mol BW.
    Obstet Gynecol; 2019 Mar 04; 133(3):459-467. PubMed ID: 30741812
    [Abstract] [Full Text] [Related]

  • 15. Vaginal progesterone compared with intramuscular 17-alpha-hydroxyprogesterone caproate for prevention of recurrent preterm birth in singleton gestations: a systematic review and meta-analysis.
    Boelig RC, Locci M, Saccone G, Gragnano E, Berghella V.
    Am J Obstet Gynecol MFM; 2022 Sep 04; 4(5):100658. PubMed ID: 35562009
    [Abstract] [Full Text] [Related]

  • 16. Early vaginal progesterone versus placebo in twin pregnancies for the prevention of spontaneous preterm birth: a randomized, double-blind trial.
    Rehal A, Benkő Z, De Paco Matallana C, Syngelaki A, Janga D, Cicero S, Akolekar R, Singh M, Chaveeva P, Burgos J, Molina FS, Savvidou M, De La Calle M, Persico N, Quezada Rojas MS, Sau A, Greco E, O'Gorman N, Plasencia W, Pereira S, Jani JC, Valino N, Del Mar Gil M, Maclagan K, Wright A, Wright D, Nicolaides KH.
    Am J Obstet Gynecol; 2021 Jan 04; 224(1):86.e1-86.e19. PubMed ID: 32598909
    [Abstract] [Full Text] [Related]

  • 17. Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis.
    Norman JE, Mackenzie F, Owen P, Mactier H, Hanretty K, Cooper S, Calder A, Mires G, Danielian P, Sturgiss S, MacLennan G, Tydeman G, Thornton S, Martin B, Thornton JG, Neilson JP, Norrie J.
    Lancet; 2009 Jun 13; 373(9680):2034-40. PubMed ID: 19523680
    [Abstract] [Full Text] [Related]

  • 18. Vaginal progesterone vs intramuscular 17-hydroxyprogesterone caproate for prevention of recurrent preterm birth: a randomized controlled trial.
    Boelig RC, Schoen CN, Frey H, Gimovsky AC, Springel E, Backley S, Berghella V.
    Am J Obstet Gynecol; 2022 May 13; 226(5):722.e1-722.e12. PubMed ID: 35189093
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of two treatment strategies for the prevention of preterm birth in women identified as at risk by ultrasound (PESAPRO Trial): study protocol for a randomized controlled trial.
    Cabrera-García L, Cruz-Melguizo S, Ruiz-Antorán B, Torres F, Velasco A, Martínez-Payo C, Avendaño-Solá C, PESAPRO trial Group.
    Trials; 2015 Sep 25; 16():427. PubMed ID: 26407852
    [Abstract] [Full Text] [Related]

  • 20. Increased doses of vaginal progesterone for the prevention of preterm birth in twin pregnancies: a randomised controlled double-blind multicentre trial.
    Serra V, Perales A, Meseguer J, Parrilla JJ, Lara C, Bellver J, Grifol R, Alcover I, Sala M, Martínez-Escoriza JC, Pellicer A.
    BJOG; 2013 Jan 25; 120(1):50-7. PubMed ID: 22882759
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.